Profile
Lance Baldo founded MedAptus, Inc. Presently, Dr. Baldo is Chief Medical Officer of Adaptive Biotechnologies Corp. In the past Dr. Baldo was Senior Vice President & Head-US Medical Affairs at Genentech, Inc. and Vice President-Global Medical Science & Affairs at The Medicines Co. Lance Baldo received an undergraduate degree from The Johns Hopkins University and a doctorate from The University of Connecticut School of Medicine.
Former positions of Lance Baldo
| Companies | Position | End |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | 2022-03-24 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2019-03-31 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 2010-01-31 |
MedAptus, Inc.
 MedAptus, Inc. Information Technology ServicesTechnology Services MedAptus, Inc. operates as a healthcare information technology company which provides revenue cycle solutions to medical group practices and integrated delivery systems. It offers professional charge capture a flexible, scalable solution in use at single-specialty groups, multi-specialty clinics, academic centers and IDNs; technical charge capture eases and standardizes facility billing by automating the charge creation process across an outpatient care team; and infusion services charge capture which streamline and improve infusion coding by compliant capture. The company was founded by Lance Baldo and Malcolm M. Lloyd in 1999 and is headquartered in Boston, MA. | Founder | - |
Training of Lance Baldo
| The Johns Hopkins University | Undergraduate Degree |
| The University of Connecticut School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
MedAptus, Inc.
MedAptus, Inc. Information Technology ServicesTechnology Services MedAptus, Inc. operates as a healthcare information technology company which provides revenue cycle solutions to medical group practices and integrated delivery systems. It offers professional charge capture a flexible, scalable solution in use at single-specialty groups, multi-specialty clinics, academic centers and IDNs; technical charge capture eases and standardizes facility billing by automating the charge creation process across an outpatient care team; and infusion services charge capture which streamline and improve infusion coding by compliant capture. The company was founded by Lance Baldo and Malcolm M. Lloyd in 1999 and is headquartered in Boston, MA. | Technology Services |
- Stock Market
- Insiders
- Lance Baldo
